#medtech #lungcancer #innovation | Peregrine Ventures

Funding Rounds

▤ Summary

Peregrine Ventures highlights Snipe Medical as a portfolio company working on minimally invasive lung cancer treatment. The startup’s IRE ablation device aims to reduce patient risk and recovery time compared with traditional therapies. The post also points to SHAAR’s MedTech program as a support platform that helps accelerate early-stage healthcare innovators. Snipe Medical says it is preparing for the next phase of growth and clinical plans. This makes the item relevant to healthtech and medtech audiences tracking emerging medical technology companies.

$ Funding

$
Amount None Total raised
□
Date February 7, 2023 Announcement date
◎
Investors World Health Organization, Arieli Capital Lead investors
▥
Company - Funded company

▥ Classifications

industries
No industries detected
applications
No applications detected

◇ AskAI Classifications

Labels
No AI classifications detected

▦ Linked Companies